Plus Therapeutics, Inc.
PSTV
$0.5401
-$0.0878-13.98%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.82% | -130.36% | 2.54% | 15.03% | 22.92% |
| Total Depreciation and Amortization | -3.46% | 4.16% | 5.10% | -16.96% | -22.62% |
| Total Amortization of Deferred Charges | -100.00% | -97.14% | -89.47% | -79.17% | -68.62% |
| Total Other Non-Cash Items | 1,710.88% | 1,311.04% | -293.71% | -326.14% | -161.18% |
| Change in Net Operating Assets | -226.28% | 353.75% | 388.71% | 621.73% | 427.55% |
| Cash from Operations | -69.58% | -5.55% | 17.87% | 15.00% | 33.83% |
| Capital Expenditure | 79.77% | -5.83% | 8.75% | 28.05% | 35.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 74.93% | 66.05% | -- | -3,552.99% | -3,557.26% |
| Cash from Investing | 75.84% | 55.74% | -2,469.38% | -3,168.99% | -2,675.00% |
| Total Debt Issued | 13.55% | -- | -- | -- | -- |
| Total Debt Repaid | -45.73% | -558.52% | -148.51% | -173.51% | -198.51% |
| Issuance of Common Stock | 76.56% | 395.94% | 32.26% | 25.24% | 2.06% |
| Repurchase of Common Stock | 100.00% | 100.00% | -196.83% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 44.02% | 87.07% | 87.07% | 29.30% | 49.16% |
| Cash from Financing | 85.88% | 790.07% | 79.59% | 38.91% | 2.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 55.22% | 170.92% | 11.37% | -5.65% | 16.85% |